Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization study

Lanlan Chen1, Zhongqi Fan1, Xiaodong Sun1

  • 1Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, China.

Frontiers in Pharmacology
|September 12, 2022
PubMed